Kymera Therapeutics
KYMR
#1949
Rank
โ‚น912.16 B
Marketcap
โ‚น10,685
Share price
-3.42%
Change (1 day)
80.59%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): -โ‚น338.92

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น335.43. In 2025 the company made an earnings per share (EPS) of -โ‚น340.99 a decrease over its 2024 EPS that were of -โ‚น275.20.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น338.92-0.61%
2025-โ‚น340.9923.91%
2024-โ‚น275.2017.86%
2023-โ‚น233.50-12.5%
2022-โ‚น266.8639.81%
2021-โ‚น190.8822.84%
2020-โ‚น155.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA